• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒的异质性会影响生物分布和靶向性。

Heterogeneity in nanoparticles influences biodistribution and targeting.

作者信息

Adjei Isaac M, Peetla Chiranjeevi, Labhasetwar Vinod

机构信息

Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Nanomedicine (Lond). 2014 Feb;9(2):267-78. doi: 10.2217/nnm.13.70. Epub 2013 Jun 26.

DOI:10.2217/nnm.13.70
PMID:23799984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3883796/
Abstract

AIM

A large fraction of the administered dose of nanoparticles (NPs) localizes into nontarget tissue, which could be due to the heterogeneous population of NPs.

MATERIALS & METHODS: To investigate the impact of the above issue, we simultaneously tracked the biodistribution using optical imaging of two different sized poly(d,l-lactide co-glycolide) NPs, which also varied in their surface charge and texture, in a prostate tumor xenograft mouse model.

RESULTS

Although formulated using the same polymer and emulsifier concentration, small NPs were neutral (S-neutral-NPs), whereas large NPs were anionic (L-anionic-NPs). Simultaneous injection of these NPs, representing heterogeneity, shows significantly different biodistribution. S-neutral-NPs demonstrated longer circulation time than L-anionic-NPs (t1/2 = 96 vs 13 min); accounted for 75% of total NPs accumulated in the tumor; and showed 13-fold greater tumor to liver signal intensity ratio than L-anionic-NPs.

CONCLUSION

The data underscore the importance of formulating nanocarriers of specific properties to enhance their targeting efficacy.

摘要

目的

纳米颗粒(NPs)给药剂量的很大一部分会定位于非靶组织,这可能归因于NPs的异质性群体。

材料与方法

为研究上述问题的影响,我们在前列腺肿瘤异种移植小鼠模型中,使用光学成像同时追踪了两种不同尺寸的聚(d,l-丙交酯乙交酯)NPs的生物分布,这两种NPs在表面电荷和质地方面也存在差异。

结果

尽管使用相同的聚合物和乳化剂浓度进行配制,但小尺寸NPs呈中性(S-中性-NPs),而大尺寸NPs呈阴离子性(L-阴离子-NPs)。同时注射这些代表异质性的NPs,显示出明显不同的生物分布。S-中性-NPs的循环时间比L-阴离子-NPs长(t1/2 = 96分钟对13分钟);占肿瘤中积累的总NPs的75%;并且肿瘤与肝脏的信号强度比是L-阴离子-NPs的13倍。

结论

数据强调了配制具有特定性质的纳米载体以提高其靶向效果的重要性。

相似文献

1
Heterogeneity in nanoparticles influences biodistribution and targeting.纳米颗粒的异质性会影响生物分布和靶向性。
Nanomedicine (Lond). 2014 Feb;9(2):267-78. doi: 10.2217/nnm.13.70. Epub 2013 Jun 26.
2
Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.在前列腺癌骨内模型中,用表面调制的载药纳米颗粒抑制骨质流失。
J Control Release. 2016 Jun 28;232:83-92. doi: 10.1016/j.jconrel.2016.04.019. Epub 2016 Apr 15.
3
Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.近红外荧光染料透明质酸制剂优化前列腺肿瘤异种移植中的手术成像。
Acta Biomater. 2018 Jul 15;75:323-333. doi: 10.1016/j.actbio.2018.06.016. Epub 2018 Jun 8.
4
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.用于体内靶向给药的功能化聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的制剂
Biomaterials. 2007 Feb;28(5):869-76. doi: 10.1016/j.biomaterials.2006.09.047. Epub 2006 Oct 20.
5
Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.紫杉醇在可生物降解的自组装核壳聚(丙交酯-乙交酯-富马酸环氧乙烷)纳米颗粒中的细胞毒性。
Pharm Res. 2008 Jul;25(7):1552-62. doi: 10.1007/s11095-007-9513-z. Epub 2008 Jan 15.
6
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.用于静脉注射的载多西他赛聚乳酸-羟基乙酸共聚物和聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒:药代动力学和生物分布特征
Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017.
7
Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.聚乙二醇大分子表面接枝密度对用于皮下肿瘤体内成像的双荧光硅纳米粒子的影响。
Biochim Biophys Acta Gen Subj. 2017 Jun;1861(6):1587-1596. doi: 10.1016/j.bbagen.2017.01.036. Epub 2017 Feb 4.
8
Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.用于阿霉素靶向递送的生物素共轭多层聚[D,L-丙交酯-共-乙交酯]-卵磷脂-聚乙二醇纳米颗粒
J Pharm Sci. 2016 Sep;105(9):2949-2958. doi: 10.1016/j.xphs.2016.03.038. Epub 2016 May 18.
9
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.抗 HER2 包被紫杉醇负载免疫纳米粒子治疗播散性卵巢癌的疗效:在小鼠体内的治疗效果和生物分布。
J Control Release. 2010 Jun 15;144(3):324-31. doi: 10.1016/j.jconrel.2010.02.026. Epub 2010 Feb 25.
10
Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with Co-porphyrin: Oleylamine ensures stable chelation of cobalt in nanoparticles that accumulate in tumors.钴卟啉标记的疏水性纳米颗粒的螯合、制剂、包封、保留和体内生物分布:油胺确保了纳米颗粒中钴的稳定螯合,从而使纳米颗粒在肿瘤中积累。
J Control Release. 2018 Dec 10;291:11-25. doi: 10.1016/j.jconrel.2018.09.027. Epub 2018 Oct 3.

引用本文的文献

1
Macromolecular Cargo Encapsulation via In Vitro Assembly of Two-Component Protein Nanoparticles.通过两亲性蛋白纳米粒子的体外组装实现大分子货物的封装。
Adv Healthc Mater. 2024 Apr;13(11):e2303910. doi: 10.1002/adhm.202303910. Epub 2024 Feb 11.
2
Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.纳米治疗学的异质性:来源、影响与解决方案。
Small. 2024 Apr;20(17):e2307502. doi: 10.1002/smll.202307502. Epub 2023 Dec 5.
3
Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model.

本文引用的文献

1
Permission to enter cell by shape: nanodisk vs nanosphere.形状许可进入细胞:纳米盘与纳米球。
ACS Appl Mater Interfaces. 2012 Aug;4(8):4099-105. doi: 10.1021/am300840p. Epub 2012 Aug 7.
2
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery.分子自组装核酸纳米颗粒用于靶向体内 siRNA 递送。
Nat Nanotechnol. 2012 Jun 3;7(6):389-93. doi: 10.1038/nnano.2012.73.
3
The preferential targeting of the diseased microvasculature by disk-like particles.盘状颗粒对病变微血管的优先靶向作用。
催化抗氧化纳米粒子减轻脊髓损伤模型中的继发性损伤进展并促进功能恢复。
J Control Release. 2023 Dec;364:109-123. doi: 10.1016/j.jconrel.2023.10.028. Epub 2023 Oct 27.
4
Single Particle Chemical Characterisation of Nanoformulations for Cargo Delivery.用于货物递送的纳米制剂的单颗粒化学特征分析。
AAPS J. 2023 Oct 2;25(6):94. doi: 10.1208/s12248-023-00855-w.
5
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors.通过临床肿瘤中的 EPR 效应提高纳米医学肿瘤靶向性的展望。
Int J Mol Sci. 2023 Jun 13;24(12):10082. doi: 10.3390/ijms241210082.
6
Sex-based differences of antioxidant enzyme nanoparticle effects following traumatic brain injury.创伤性脑损伤后抗氧化酶纳米颗粒作用的性别差异。
J Control Release. 2023 Mar;355:149-159. doi: 10.1016/j.jconrel.2023.01.065. Epub 2023 Feb 6.
7
Flash Technology-Based Self-Assembly in Nanoformulation: From Fabrication to Biomedical Applications.基于闪蒸技术的纳米制剂自组装:从制备到生物医学应用
Mater Today (Kidlington). 2021 Jan-Feb;42:99-116. doi: 10.1016/j.mattod.2020.08.019. Epub 2020 Nov 2.
8
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment.基于小干扰RNA的纳米疗法在癌症治疗中的临床进展
Pharmaceutics. 2021 Jul 2;13(7):1009. doi: 10.3390/pharmaceutics13071009.
9
Rationally Designed DNA Nanostructures for Drug Delivery.用于药物递送的合理设计的DNA纳米结构
Front Chem. 2020 Sep 24;8:751. doi: 10.3389/fchem.2020.00751. eCollection 2020.
10
Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury.评估静脉注射纳米颗粒在大鼠和猪脊髓损伤挫伤模型病变部位的可及性。
J Control Release. 2019 May 28;302:160-168. doi: 10.1016/j.jconrel.2019.03.026. Epub 2019 Mar 28.
Biomaterials. 2012 Aug;33(22):5504-13. doi: 10.1016/j.biomaterials.2012.04.027. Epub 2012 May 11.
4
Nanoparticle-mediated p53 gene therapy for tumor inhibition.纳米颗粒介导的 p53 基因治疗抑制肿瘤。
Drug Deliv Transl Res. 2011 Feb;1(1):43-52. doi: 10.1007/s13346-010-0008-9.
5
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors.整合活体显微镜检查和数学建模以优化纳米治疗剂向肿瘤的递送。
AIP Adv. 2012 Mar;2(1):11208. doi: 10.1063/1.3699060. Epub 2012 Mar 22.
6
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.肿瘤血管正常化以依赖尺寸的方式改善了纳米药物的递送。
Nat Nanotechnol. 2012 Apr 8;7(6):383-8. doi: 10.1038/nnano.2012.45.
7
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.纳米颗粒的大小是人类血浆电晕的关键理化决定因素:全面的定量蛋白质组学分析。
ACS Nano. 2011 Sep 27;5(9):7155-67. doi: 10.1021/nn201950e. Epub 2011 Aug 25.
8
The evolution of the protein corona around nanoparticles: a test study.蛋白质冠在纳米颗粒周围的演变:一项测试研究。
ACS Nano. 2011 Sep 27;5(9):7503-9. doi: 10.1021/nn202458g. Epub 2011 Aug 26.
9
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.表面电荷对基于聚乙二醇-胆酸的胶束纳米粒体内分布的影响。
Biomaterials. 2011 May;32(13):3435-46. doi: 10.1016/j.biomaterials.2011.01.021. Epub 2011 Feb 4.
10
Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors.肿瘤中磁性纳米粒子的光学成像和磁场靶向。
ACS Nano. 2010 Sep 28;4(9):5217-24. doi: 10.1021/nn101427t.